Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The complement system is a crucial part of the innate immune system. This entry describes the modulation of the complement system via antibodies, specifically IgG and IgA. IgG antibodies can inhibit the formation of the membrane attack complex (MAC), preventing cell lysis. IgA antibodies activate the complement system via the alternative or lectin pathways, promoting pathogen clearance through opsonization and phagocytosis. Modulation of this system is a potential therapeutic target for infections and autoimmune diseases.
Inhibition of membrane attack complex (MAC) formation by IgG antibodies; complement activation and clearance by IgA antibodies via alternative or lectin pathway induction
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Complement system components involved in MAC inhibition and activation.